These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 11916106

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anti-obesity drugs: what does sibutramine offer? An analysis of its potential contribution to obesity treatment.
    Van Gaal LF, Wauters MA, De Leeuw IH.
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():35-40. PubMed ID: 9792480
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sibutramine and the management of obesity.
    Poston WS, Foreyt JP.
    Expert Opin Pharmacother; 2004 Mar; 5(3):633-42. PubMed ID: 15013931
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Pharmacological therapy of obesity].
    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [Abstract] [Full Text] [Related]

  • 8. Sibutramine. A review of its contribution to the management of obesity.
    McNeely W, Goa KL.
    Drugs; 1998 Dec; 56(6):1093-124. PubMed ID: 9878996
    [Abstract] [Full Text] [Related]

  • 9. What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice.
    Astrup A, Lundsgaard C.
    Exp Clin Endocrinol Diabetes; 1998 Dec; 106 Suppl 2():29-34. PubMed ID: 9792479
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The importance of obesity in diabetes and its treatment with sibutramine.
    Van Gaal LF, Peiffer FW.
    Int J Obes Relat Metab Disord; 2001 Dec; 25 Suppl 4():S24-8. PubMed ID: 11916103
    [Abstract] [Full Text] [Related]

  • 12. No compelling evidence that sibutramine prolongs life in rodents despite providing a dose-dependent reduction in body weight.
    Smith DL, Robertson HT, Desmond RA, Nagy TR, Allison DB.
    Int J Obes (Lond); 2011 May; 35(5):652-7. PubMed ID: 21079617
    [Abstract] [Full Text] [Related]

  • 13. Sibutramine and the sympathetic nervous system in obese humans.
    Haynes WG, Egri Z.
    Clin Auton Res; 2005 Jun; 15(3):189-92. PubMed ID: 15944867
    [No Abstract] [Full Text] [Related]

  • 14. Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity.
    Smith IG, Goulder MA, Sibutramine Clinical Study 1047 Team.
    J Fam Pract; 2001 Jun; 50(6):505-12. PubMed ID: 11407998
    [Abstract] [Full Text] [Related]

  • 15. [Sibutramine, an upcoming drug for weight loss acting on energy consumption and energy expenditure].
    Astrup A.
    Acta Med Austriaca; 1998 Jun; 25(4-5):146-9. PubMed ID: 9879391
    [Abstract] [Full Text] [Related]

  • 16. Inverse agonism at α2A adrenoceptors augments the hypophagic effect of sibutramine in rats.
    Janhunen SK, van der Zwaal EM, la Fleur SE, Adan RA.
    Obesity (Silver Spring); 2011 Oct; 19(10):1979-86. PubMed ID: 21475142
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study.
    Hanotin C, Thomas F, Jones SP, Leutenegger E, Drouin P.
    Int J Obes Relat Metab Disord; 1998 Jan; 22(1):32-8. PubMed ID: 9481597
    [Abstract] [Full Text] [Related]

  • 18. The effect of sibutramine intake on resting and exercise physiological responses.
    Rotstein A, Inbar O, Vaisman N.
    Ann Nutr Metab; 2008 Jan; 52(1):17-23. PubMed ID: 18230966
    [Abstract] [Full Text] [Related]

  • 19. Sibutramine and energy balance.
    Astrup A, Hansen DL, Lundsgaard C, Toubro S.
    Int J Obes Relat Metab Disord; 1998 Aug; 22 Suppl 1():S30-5; discussion S36-7, S42. PubMed ID: 9758241
    [Abstract] [Full Text] [Related]

  • 20. A benefit-risk assessment of sibutramine in the management of obesity.
    Nisoli E, Carruba MO.
    Drug Saf; 2003 Aug; 26(14):1027-48. PubMed ID: 14583064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.